Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-05-30 Sale |
2025-06-03 4:10 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
50,937 | $305 | $15,535,784 | 72,024 (Indirect Direct) |
View |
| 2025-05-15 Sale |
2025-05-19 4:17 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
11,250 | $277.71 | $3,124,217 | 20,804 (Indirect Direct) |
View |
| 2024-08-29 Purchase |
2025-05-12 4:05 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director |
36 | $287.85 | $10,363 | 2,333 (Direct) |
View |
| 2025-04-16 Sale |
2025-05-12 4:05 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director |
36 | $232.86 | $8,383 | 2,333 (Direct) |
View |
| 2025-03-21 Sale |
2025-03-25 4:10 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
9,766 | $293.36 | $2,864,985 | 20,902 (Indirect Direct) |
View |
| 2025-03-24 Sale |
2025-03-25 4:09 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
7,440 | $299 | $2,224,560 | 28,036 (Indirect Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:22 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,755 | $242.94 | $669,304 | 21,857 (Indirect Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:22 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
471 | $243.78 | $114,820 | 35,830 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
2,557 | $242.92 | $621,150 | 33,042 (Indirect Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,264 | $243.78 | $308,141 | 57,608 (Indirect Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:20 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
3,877 | $243.79 | $945,165 | 135,335 (Indirect Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:32 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
2,900 | $241.69 | $700,894 | 90,875 (Indirect Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:31 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
796 | $241.7 | $192,390 | 35,863 (Indirect Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:31 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
513 | $241.68 | $123,983 | 16,011 (Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:31 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
935 | $241.69 | $225,977 | 15,551 (Indirect Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:30 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
496 | $241.69 | $119,878 | 12,922 (Indirect Direct) |
View |
| 2025-02-14 Sale |
2025-02-18 4:49 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
1,213 | $255.17 | $309,527 | 81,933 (Indirect Direct) |
View |
| 2025-02-14 Sale |
2025-02-18 4:47 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
967 | $255.17 | $246,750 | 32,843 (Indirect Direct) |
View |
| 2025-02-14 Sale |
2025-02-18 4:47 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,103 | $252.71 | $531,448 | 13,418 (Indirect Direct) |
View |
| 2025-02-14 Sale |
2025-02-18 4:47 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
3,109 | $253.43 | $787,904 | 12,670 (Indirect Direct) |
View |
| 2025-01-27 Sale |
2025-01-29 4:03 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
52,592 | $285 | $14,988,720 | 12,670 (Indirect Direct) |
View |
| 2025-01-23 Sale |
2025-01-24 4:10 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
11,250 | $275 | $3,093,750 | 266,899 (Indirect Direct) |
View |
| 2024-12-12 Sale |
2024-12-13 4:13 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,752 | $251 | $439,760 | 16,386 (Indirect Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:22 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
5,219 | $250.98 | $1,309,853 | 79,287 (Indirect Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:22 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,682 | $250.98 | $422,144 | 18,138 (Indirect Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,682 | $250.98 | $422,144 | 30,701 (Indirect Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
1,469 | $250.98 | $368,686 | 13,191 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-07-01 Option Award |
2025-07-02 4:26 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
7,763 | $0 | 21,801 (Direct) |
View |
| 2025-05-30 Exercise |
2025-06-03 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
24,161 | $119.13 | 72,024 (Direct) |
View |
| 2025-05-30 Exercise |
2025-06-03 4:10 pm |
N/A 2030-02-25 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
50,937 | $0 | 72,024 (Direct) |
View |
| 2025-05-30 Exercise |
2025-06-03 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
26,776 | $118.05 | 72,024 (Direct) |
View |
| 2025-05-15 Exercise |
2025-05-19 4:17 pm |
2016-06-01 2025-06-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
11,250 | $0 | 20,804 (Direct) |
View |
| 2025-05-15 Exercise |
2025-05-19 4:17 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
11,250 | $131.21 | 20,804 (Direct) |
View |
| 2025-05-16 Gift |
2025-05-19 4:16 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
8,376 | $0 | 49,355 (Direct) |
View |
| 2025-05-08 Option Award |
2025-05-12 4:07 pm |
2026-05-08 2035-05-08 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
2,333 | $0 | 5,969 (Direct) |
View |
| 2025-05-08 Option Award |
2025-05-12 4:07 pm |
2026-05-08 2035-05-08 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
2,333 | $0 | 22,362 (Direct) |
View |
| 2025-05-08 Option Award |
2025-05-12 4:06 pm |
2026-05-08 2035-05-08 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BRANDICOURT OLIVIER Director |
2,333 | $0 | 2,333 (Direct) |
View |
| 2025-05-08 Option Award |
2025-05-12 4:06 pm |
2026-05-08 2035-05-08 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | HAMBURG MARGARET A Director |
2,333 | $0 | 2,469 (Direct) |
View |
| 2025-05-08 Option Award |
2025-05-12 4:05 pm |
2026-05-08 2035-05-08 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | KELLOGG PETER N Director |
2,333 | $0 | 2,333 (Direct) |
View |
| 2025-05-08 Option Award |
2025-05-12 4:05 pm |
2026-05-08 2035-05-08 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
2,333 | $0 | 30,369 (Direct) |
View |
| 2025-05-08 Option Award |
2025-05-12 4:05 pm |
2026-05-08 2035-05-08 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director |
2,333 | $0 | 2,333 (Direct) |
View |
| 2025-05-08 Option Award |
2025-05-12 4:04 pm |
2026-05-08 2035-05-08 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
2,333 | $0 | 13,519 (Direct) |
View |
| 2025-05-08 Option Award |
2025-05-12 4:04 pm |
2026-05-08 2035-05-08 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director |
2,333 | $0 | 4,333 (Direct) |
View |
| 2025-05-08 Option Award |
2025-05-12 4:03 pm |
2026-05-08 2035-05-08 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Bertozzi Carolyn R Director |
2,333 | $0 | 2,333 (Direct) |
View |
| 2025-05-02 Gift |
2025-05-06 5:05 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
41,311 | $0 | 57,731 (Direct) |
View |
| 2025-03-24 Exercise |
2025-03-25 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
5,445 | $42.22 | 20,902 (Direct) |
View |
| 2025-03-24 Exercise |
2025-03-25 4:10 pm |
N/A 2026-12-20 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
5,445 | $0 | 20,902 (Direct) |
View |
| 2025-03-24 Exercise |
2025-03-25 4:09 pm |
N/A 2025-12-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
7,440 | $0 | 28,036 (Direct) |
View |
| 2025-03-24 Exercise |
2025-03-25 4:09 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
7,440 | $88.95 | 28,036 (Direct) |
View |
| 2025-03-13 Exercise |
2025-03-14 4:16 pm |
2016-06-01 2025-06-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
2,750 | $0 | 11,186 (Direct) |
View |
| 2025-03-13 Exercise |
2025-03-14 4:16 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
2,750 | $131.21 | 11,186 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:23 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Hesslein Robert W. EVP, CLO and Secretary |
2,286 | $0 | 9,531 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:22 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
11,690 | $0 | 21,857 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:22 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
21,956 | $0 | 35,830 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:21 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
21,956 | $0 | 33,042 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:21 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
24,917 | $0 | 57,608 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:20 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
54,258 | $0 | 135,335 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 4:32 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
5,921 | $0 | 90,875 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 4:31 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,908 | $0 | 35,863 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 4:31 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
1,667 | $0 | 16,011 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 4:31 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,908 | $0 | 15,551 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:49 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
3,859 | $0 | 81,933 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:47 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,109 | $0 | 32,843 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:47 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,103 | $0 | 13,418 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:47 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
3,109 | $0 | 12,670 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 4:03 pm |
2019-08-06 2025-12-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
48,876 | $0 | 12,670 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 4:03 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
48,876 | $88.95 | 12,670 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-24 4:10 pm |
2016-06-01 2025-06-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
11,250 | $0 | 266,899 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-24 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
11,250 | $131.21 | 266,899 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:22 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
10,658 | $0 | 79,287 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:22 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
3,434 | $0 | 18,138 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:21 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,434 | $0 | 30,701 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:21 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
3,000 | $0 | 13,191 (Direct) |
View |